Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation

EuroIntervention

Volumn 7, Issue 2, 2011, Pages 184-191

  Van Mieghem, Nicolas M ^a   Nuis, Rutger Jan ^a   Tzikas, Apostolos ^a   Piazza, Nicolo ^a   Schultz, Carl ^a   Serruys, Patrick W ^a   De Jaegere, Peter P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Anaemia; Aortic stenosis; TAVI

Indexed keywords

HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELODYSPLASTIC SYNDROME; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PROGNOSIS; THROMBOCYTOPENIA; TRANSCATHETER AORTIC VALVE IMPLANTATION; AGED; AORTA VALVE; BLOOD TRANSFUSION; FOLLOW UP; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ANEMIA; AORTIC VALVE; BLOOD TRANSFUSION; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 80054052429     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I2A32     Document Type: Article

References (37)

1. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Jr., Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, American College of Cardiology/American Heart Association Task Force on Practice G. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 52:e1-142.
2. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A, Task Force on the Management of Valvular Hearth Disease of the European Society of C, Guidelines ESCCfP. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-268. (Pubitemid 46276943)
3. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-249.
4. Webb JG, Altwegg L, Masson JB, Al Bugami S, Al Ali A, Boone RA. A new transcatheter aortic valve and percutaneous valve delivery system. J Am Coll Cardiol 2009;53:1855-1858.
5. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second-and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76. (Pubitemid 46970878)
6. Bleiziffer S, Ruge H, Mazzitelli D, Hutter A, Opitz A, Bauernschmitt R, Lange R. Survival after transapical and transfemoral aortic valve implantation: talking about two different patient populations. J Thorac Cardiovasc Surg 2009;138:1073-1080.
7. Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, Devarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, Delarochelliere R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter Aortic Valve Implantation for the Treatment of Severe Symptomatic Aortic Stenosis in Patients at Very High or Prohibitive Surgical Risk Acute and Late Outcomes of the Multicenter Canadian Experience. J Am Coll Cardiol 2010;55:1080-90
8. Maluenda G, Lemesle G, Collins SD, Ben-Dor I, Syed AI, Torguson R, Kaneshige K, Xue Z, Pakala R, Suddath WO, Satler LF, Kent KM, Lindsay J, Pichard AD, Waksman R. The clinical significance of hematocrit values before and after percutaneous coronary intervention. Am Heart J 2009;158:1024-1030.
9. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, Gibson CM, Braunwald E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005;111:2042-2049. (Pubitemid 40577898)
10. Cladellas M, Bruguera J, Comin J, Vila J, de Jaime E, Marti J, Gomez M. Is pre-operative anaemia a risk marker for in-hospital mortality and morbidity after valve replacement? Eur Heart J 2006; 27:1093-1099.
11. van Straten AH, Hamad MA, van Zundert AJ, Martens EJ, Schonberger JP, de Wolf AM. Preoperative hemoglobin level as a predictor of survival after coronary artery bypass grafting: a comparison with the matched general population. Circulation 2009; 120:118-125.
12. Karkouti K, Wijeysundera DN, Beattie WS, Reducing Bleeding in Cardiac Surgery I. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation 2008;117: 478-484.
13. Buellesfeld L, Wenaweser P, Gerckens U, Mueller R, Sauren B, Latsios G, Zickmann B, Hellige G, Windecker S, Grube E. Transcatheter aortic valve implantation: predictors of procedural success--the Siegburg-Bern experience. Eur Heart J 2010;31: 984-91.
14. de Jaegere P, van Dijk LC, Laborde JC, Sianos G, Orellana Ramos FJ, Lighart J, Kappetein AP, Vander Ent M, Serruys PW. True percutaneous implantation of the CoreValve aortic valve prosthesis by the combined use of ultrasound guided vascular access, Prostar(R) XL and the TandemHeart(R). EuroIntervention 2007; 2:500-505.
15. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med 1997;336:1689-1696.
16. Landefeld CS, Cook EF, Flatley M, Weisberg M, Goldman L. Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med 1987;82:703-713.
17. Garcia-Garcia HM, van Mieghem CA, Gonzalo N, Meijboom WB, Weustink AC, Onuma Y, Mollet NR, Schultz CJ, Meliga E, van der Ent M, Sianos G, Goedhart D, den Boer A, de Feyter P, Serruys PW. Computed tomography in total coronary occlusions (CTTO registry): radiation exposure and predictors of successful percutaneous intervention. EuroIntervention 2009;4:607-616.
18. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack MM, R., Miller C, Morel M, Petersen JP, J.J., Takkenberg JJM, Vahanian A, van Es G, Vranckx P, Smith C, Webb JG, Mohr F, Windecker S, Serruys PW. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation Clinical Trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011;57:253-69.
19. Nikolsky E, Aymong ED, Halkin A, Grines CL, Cox DA, Garcia E, Mehran R, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Cohen DA, Negoita M, Lansky AJ, Stone GW. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 2004; 44:547-553. (Pubitemid 39078177)
20. Nikolsky E, Mehran R, Aymong ED, Mintz GS, Lansky AJ, Lasic Z, Negoita M, Fahy M, Pocock SJ, Na Y, Krieger S, Moses JW, Stone GW, Leon MB, Dangas G. Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. Am J Cardiol 2004;94:1023-1027. (Pubitemid 39336435)
21. Kulier A, Levin J, Moser R, Rumpold-Seitlinger G, Tudor IC, Snyder-Ramos SA, Moehnle P, Mangano DT, Investigators of the Multicenter Study of Perioperative Ischemia Research G, Ischemia Research and Education F. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007;116:471-479.
22. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001;345:1230-1236. (Pubitemid 34951486)
23. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004;104:2263-2268. (Pubitemid 39331821)
24. Rockey DC, Cello JP. Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. N Engl J Med 1993;329: 1691-1695. (Pubitemid 23346919)
25. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-1023.
26. Doyle BJ, Rihal CS, Gastineau DA, Holmes DR, Jr. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. J Am Coll Cardiol 2009;53:2019-2027.
27. Twomley KM, Rao SV, Becker RC. Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions. J Thromb Thrombolysis 2006;21:167-174.
28. Bagur R, Webb JG, Nietlispach F, Dumont E, De Larochelliere R, Doyle D, Masson JB, Gutierrez MJ, Clavel MA, Bertrand OF, Pibarot P, Rodes-Cabau J. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 2010;31:865-874.
29. Aregger F, Wenaweser P, Hellige GJ, Kadner A, Carrel T, Windecker S, Frey FJ. Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant 2009;24:2175-2179.
30. Moore FA, Moore EE, Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg 1997; 132:620-624; discussion 624-625.
31. Nuis RJ, Van Mieghem NM, Tzikas A, Piazza N, Otten AM, Cheng J, van Domburg RT, Betjes M, Serruys PW, de Jaegere PP. Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2011;77:881-889.
32. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med1999;340:409-417. (Pubitemid 29084771)
33. Hebert PC, McDonald BJ, Tinmouth A. Clinical consequences of anemia and red cell transfusion in the critically ill. Crit Care Clin 2004;20:225-235. (Pubitemid 38596813)
34. Alexander KP, Chen AY, Wang TY, Rao SV, Newby LK, LaPointe NM, Ohman EM, Roe MT, Boden WE, Harrington RA, Peterson ED, Investigators C. Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes. Am Heart J2008;155:1047-1053.
35. Maluenda G, Lemesle G, Ben-Dor I, Collins SD, Syed AI, Li Y, Torguson R, Kaneshige K, Xue Z, Suddath WO, Satler LF, Kent KM, Lindsay J, Pichard AD, Waksman R. Value of blood transfusion in patients with a blood hematocrit of 24% to 30% after percutaneous coronary intervention. Am J Cardiol 2009;104:1069-1073.
36. Marsden PA. Treatment of anemia in chronic kidney disease-strategies based on evidence. N Engl J Med 2009;361:2089-2090.
37. Unger EF, Thompson AM, Blank MJ, Temple R. Erythropoiesis-stimulating agents--time for a reevaluation. N Engl J Med 2010; 362:189-192.